European Society of Cardiology: cardiovascular disease statistics 2021
Aims This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …
expands upon the widely cited 2019 report in presenting cardiovascular disease (CVD) …
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
The coexistence of type 2 diabetes mellitus (T2DM) and heart failure (HF), either with
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) …
reduced (HFrEF) or preserved ejection fraction (HFpEF), is frequent (30–40% of patients) …
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
MA Bethel, RA Patel, P Merrill… - The lancet Diabetes & …, 2018 - thelancet.com
Summary Background Glucagon-like peptide-1 (GLP-1) receptor agonists are effective
glucose-lowering drugs. Findings from cardiovascular outcome trials showed cardiovascular …
glucose-lowering drugs. Findings from cardiovascular outcome trials showed cardiovascular …
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart …
Authors/Task Force Members… - European heart …, 2012 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …
research, but also the creation of educational tools and implementation programmes for the …
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST …
Authors/Task Force Members, PG Steg… - European heart …, 2012 - academic.oup.com
The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …
research, but also the creation of educational tools and implementation programmes for the …
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European …
Task Force Members, G Montalescot… - European heart …, 2013 - academic.oup.com
Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …
is recommended in the guidelines, thus completing the loop between clinical research …
[HTML][HTML] Rivaroxaban with or without aspirin in stable cardiovascular disease
Background We evaluated whether rivaroxaban alone or in combination with aspirin would
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …
be more effective than aspirin alone for secondary cardiovascular prevention. Methods In …
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Background Trials of statin therapy have had conflicting findings on the risk of development
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …
of diabetes mellitus in patients given statins. We aimed to establish by a meta-analysis of …
[HTML][HTML] Initial invasive or conservative strategy for stable coronary disease
DJ Maron, JS Hochman, HR Reynolds… - … England Journal of …, 2020 - Mass Medical Soc
Background Among patients with stable coronary disease and moderate or severe ischemia,
whether clinical outcomes are better in those who receive an invasive intervention plus …
whether clinical outcomes are better in those who receive an invasive intervention plus …
[HTML][HTML] Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
RR Holman, MA Bethel, RJ Mentz… - … England Journal of …, 2017 - Mass Medical Soc
Background The cardiovascular effects of adding once-weekly treatment with exenatide to
usual care in patients with type 2 diabetes are unknown. Methods We randomly assigned …
usual care in patients with type 2 diabetes are unknown. Methods We randomly assigned …